Takeda Pharmaceutical (TAK) Free Cash Flow (2018 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Free Cash Flow of $1.1 billion for Q2 2026, down 37.45% year-over-year from $1.8 billion in Q2 2025, and up 404.87% quarter-over-quarter from -$373.4 million in Q1 2026.
Takeda Pharmaceutical (TAK) Free Cash Flow (2018 - 2026) Analysis & Trends
Takeda Pharmaceutical's Free Cash Flow history runs 9 years deep, the most recent figure standing at $1.1 billion for Q2 2026.
- In Q2 2026, Free Cash Flow fell 37.45% year-over-year to $1.1 billion; the TTM figure through Jun 2026 stood at $6.3 billion (up 5.0% YoY), while the FY2026 annual figure was $6.9 billion, up 22.65% from the prior year.
- Free Cash Flow for Q2 2026 stood at $1.1 billion, up from -$373.4 million in the prior quarter.
- The five-year high for Free Cash Flow was $2.9 billion in Q4 2022, with the low at -$856.3 million in Q1 2025.
- The 5-year median for Free Cash Flow is $1.4 billion (2022), against an average of $1.4 billion.
- The sharpest annual moves came in 2024 and 2025: Free Cash Flow surged 115.45% in 2024, then tumbled 357.85% in 2025.
- Takeda Pharmaceutical's Free Cash Flow stood at $2.9 billion in 2022, then plunged by 55.07% to $1.3 billion in 2023, then surged by 115.45% to $2.8 billion in 2024, then slipped by 4.43% to $2.7 billion in 2025, then sank by 57.78% to $1.1 billion in 2026.
- Business Quant data shows TAK's Free Cash Flow at $1.1 billion in Q2 2026, -$373.4 million in Q1 2026, and $2.7 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 137.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Bn |
| Jun 30, 2026 | 1.14 Bn |
| Mar 31, 2026 | -373.37 Mn |
| Mar 31, 2026 | -373.37 Mn |
| Dec 31, 2025 | 2.70 Bn |
| Dec 31, 2025 | 2.70 Bn |
| Sep 30, 2025 | 2.84 Bn |
| Sep 30, 2025 | 2.84 Bn |
| Jun 30, 2025 | 1.82 Bn |
| Jun 30, 2025 | 1.82 Bn |
| Mar 31, 2025 | -856.28 Mn |
| Mar 31, 2025 | -856.28 Mn |
| Dec 31, 2024 | 2.82 Bn |
| Dec 31, 2024 | 2.82 Bn |
| Sep 30, 2024 | 2.22 Bn |
| Sep 30, 2024 | 2.22 Bn |
| Jun 30, 2024 | 1.46 Bn |
| Jun 30, 2024 | 1.46 Bn |
| Mar 31, 2024 | -187.02 Mn |
| Mar 31, 2024 | -187.02 Mn |